Zimmer Biomet Holdings Inc (ZBH)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 1,066,200 | 343,700 | 455,100 | -234,900 | 905,900 |
| Revenue | US$ in thousands | 7,171,400 | 6,780,400 | 7,459,000 | 6,789,700 | 7,751,900 |
| Pretax margin | 14.87% | 5.07% | 6.10% | -3.46% | 11.69% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $1,066,200K ÷ $7,171,400K
= 14.87%
The pretax margin of Zimmer Biomet Holdings Inc has displayed varying trends over the past five years. In 2023, the pretax margin reached 14.43%, representing a significant increase compared to the previous year's margin of 5.81%. This improvement indicates that the company's pre-tax profitability relative to its total revenue has strengthened notably.
In the preceding years, the pretax margin demonstrated mixed performance. In 2022 and 2021, the margins were relatively stable at 5.81% and 5.34%, respectively, showcasing consistent but modest profitability levels. However, in 2020, the company experienced a negative pretax margin of -3.91%, indicating a period of financial difficulty or losses.
The most notable performance was in 2019 when the pretax margin stood at 11.35%, reflecting a strong profitability position that year. Overall, the fluctuating pretax margin over the past five years suggests varying levels of operational efficiency and profitability for Zimmer Biomet Holdings Inc, highlighting the importance of closely monitoring financial performance metrics for comprehensive analysis and decision-making.
Peer comparison
Dec 31, 2023